Adult growth hormone deficiency increases medical costs, risk of additional health conditions

Canada to require a warning be printed on every cigarette
11 June 2022
Commercial T cell test reveals factors correlated with diminished responses to SARS-CoV-2 in clinical study subjects
11 June 2022

Adult growth hormone deficiency increases medical costs, risk of additional health conditions

Growth hormone deficiency (GHD) among adults is associated with greater medical costs and an increased rate of other health conditions compared with those without GHD, according to industry-sponsored research being presented Monday at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga.

Comments are closed.